This is an old revision of this page, as edited by Cewbot(talk | contribs) at 04:58, 21 February 2024(Maintain {{WPBS}}: 4 WikiProject templates. Keep majority rating "C" in {{WPBS}}. Remove 4 same ratings as {{WPBS}} in {{WikiProject Companies}}, {{WikiProject Pennsylvania}}, {{WikiProject Pharmacology}}, {{WikiProject United States}}.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 04:58, 21 February 2024 by Cewbot(talk | contribs)(Maintain {{WPBS}}: 4 WikiProject templates. Keep majority rating "C" in {{WPBS}}. Remove 4 same ratings as {{WPBS}} in {{WikiProject Companies}}, {{WikiProject Pennsylvania}}, {{WikiProject Pharmacology}}, {{WikiProject United States}}.)
This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles
This article is within the scope of WikiProject Pennsylvania, a collaborative effort to improve the coverage of Pennsylvania on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PennsylvaniaWikipedia:WikiProject PennsylvaniaTemplate:WikiProject PennsylvaniaPennsylvania articles
This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions.
The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.
Not sure of the protocol here, but should there not be a separate Viatris article? At the very least, the Viatris page should not link to Mylan. After all, Pfizer shareholders owned more than half of this business after the transaction. In other words, Viatris is mostly Pfizer's Upjohn subsidiary, not Mylan. So if anything, the Viatris page should be the Upjohn page, not the Mylan page. But more likely, I would imagine there should be a separate page for Viatris with Mylan and Pfizer having links as appropriate. ask123 (talk) 14:38, 6 October 2022 (UTC)[reply]
